Eli Lilly & Co Stock Latest News

Pharmaceutical firm Eli Lilly and Company (LLY) announced that it has acquired private biotech company Protomer for over $1...

Eli Lilly and Co. And Incyte reported data from their phase 3 study of baricitinib in hospitalized COVID-19...

Eli Lilly and Co. received praise from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...

Shares of Rigel Pharmaceuticals jumped more than 15% as the biotech company announced an exclusive $960 million collaboration...

Eli Lilly & Co. said new data showed that treatment with two of its antibody therapies lowered COVID-19-related...

Eli Lilly & Co. announced plans to launch a pragmatic study of its investigational antibody treatment, bamlanivimab, in...

Eli Lilly & Co. has inked an agreement to snap up Prevail Therapeutics for a total consideration of...

Eli Lilly & Co. (LLY) announced a 14.9% hike in its quarterly dividend to $0.85 per share from...

Eli Lilly & Co. and insurer UnitedHealth Group have teamed up to conduct a pragmatic study of the...

Eli Lilly has struck an $812.5 million agreement with the US government to supply an additional 650,000 vials of...

Generally, companies in the healthcare sector show resilience amid challenging macro conditions. However, certain healthcare stocks have been...

Precision BioSciences shares surged 10.7% on Nov. 20 as the biotechnology company along with Eli Lilly (LLY) announced...

Eli Lilly and Incyte announced on Thursday that the FDA had granted Emergency Use Authorization (EUA) for the...

Shares of Eli Lilly & Co. rose as much as 5% in Tuesday’s pre-market session after the US...

Eli Lilly (LLY) has been awarded a $312.5 million firm-fixed-price contract from the US army for the procurement...

Eli Lilly & Co. has struck a $375 million agreement with the US government to supply 300,000 vials of...

Eli Lilly & Co. announced on Monday that it will stop a US-based clinical trial for its COVID-19...

Eli Lilly & Co. announced a definitive agreement to snap up privately-held biotechnology company Disarm Therapeutics for $135...

Eli Lilly’s (LLY) Phase 3 trial of its leading monoclonal antibody coronavirus treatment has been paused by the US...

Antibodies to the rescue? According to a top U.S. health official, the U.S. government expects to provide 1...

Eli Lilly & Co. has entered into an agreement with the Bill & Melinda Gates Foundation, for future...

Regeneron might be hogging all the headlines with its Trump administered COVID-19 antibody cocktail REGN-COV2, but it is...

Eli Lilly said it submitted an initial request to the US Food and Drug Administration (FDA) for Emergency...

As the nation waits on edge, wondering what the President Trump’s prognosis will be, investment bank Raymond James’...

Eli Lilly (LLY) and Innovent Biologics have announced positive interim results from the ORIENT-12 study at the European...

Eli Lilly & Co said that the late-stage trial of its Verzenio treatment showed to reduce the risk...

Eli Lilly announced on Thursday that it is joining forces with Amgen to significantly boost the supply of...

Eli Lilly (LLY) has revealed positive results from the recently completed Phase 3 study Centurion for adults who took...

Eli Lilly has revealed that it has now received approval from the U.S. Food and Drug Administration (FDA)...

Morgan Stanley upgraded Eli Lilly to Buy from Hold and raised the stock’s price target to $176 (17.7%...

The pharmaceutical industry is considered to be more resilient in difficult economic times compared to other industries. However,...

Eli Lilly (LLY) and Innovent Biologics have announced that the National Medical Products Administration (NMPA) of China has...

Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC...

Eli Lilly has announced the initiation of BLAZE-2, a Phase 3 trial studying LY-CoV555 for the prevention of...

Shares of Eli Lilly & Co. (LLY) fell 5.4% on Thursday after the drugmaker disappointed its investors with...

Hutchison China MediTech (HCM) and Eli Lilly (LLY) have announced an amendment to the 2013 License and Collaboration...

Shares in Eli Lilly & Co (LLY) jumped 13% after the drugmaker reported that the results of a...

Junshi Biosciences has announced that the first healthy volunteer has been dosed in a Phase I clinical study...

Drugmaker Eli Lilly & Co (LLY) said that the U.S. Food and Drug Administration (FDA) has approved a...

Eli Lilly (LLY) has today announced patients have been dosed in the world’s first study of a potential...

Junshi Biosciences Co Ltd said on Tuesday that it is gearing up to initiate clinical trials to test...